The Role of Specific PET PSMA imaging and SBRT in the Management of Prostate Cancer

In this webinar, the experts highlight the synergy between highly sensitive imaging, the definition of an intermediate stage between non-disseminated tumor and widespread metastatic disease (oligometastatic state) and high-precision radiation therapy (Stereotactic Body Radiation Therapy - SBRT) focused to treat the oligometastatic lesions.

This webinar is already ready over. Missed the live webinar or want to rewatch it?

Speakers

Dr Jeremie Calais
Director of the Clinical Research Program of the Nuclear Medicine and Theranostics Division
UCLA, US
Dr Stefan Korber
MD, PhD First Senior Medical Doctor at Clinic for Radiation Oncology and Radiation Therapy
University Clinic of Heidelberg, Germany
Dr Kai Schubert
Medical Physicist at Clinic for Radiation Oncology and Radiation Therapy
University Clinic of Heidelberg, Germany
Topics
- Impact of PSMA PET on management of patients with oligometastatic prostate cancer.
- The Role of SBRT in the treatment of oligometastatic prostate cancer: Why & how SBRT for these patients.
- Quality assurance for SBRT treatments.